Not Found

Find information on medical topics, symptoms, drugs, procedures, news and more, written for the health care professional.

Overview of Demyelinating Disorders

By Michael C. Levin, MD, Saskatchewan Multiple Sclerosis Clinical Research Chair and Professor of Neurology and Anatomy-Cell Biology; Adjunct Professor of Neurology, College of Medicine, University of Saskatchewan; University of Tennessee Health Science Center

Click here for
Patient Education

Myelin sheaths cover many nerve fibers in the central and peripheral nervous system; they accelerate axonal transmission of neural impulses. Disorders that affect myelin interrupt nerve transmission; symptoms may reflect deficits in any part of the nervous system.

Myelin formed by oligodendroglia in the CNS differs chemically and immunologically from that formed by Schwann cells peripherally. Thus, some myelin disorders (eg, Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, some other peripheral nerve polyneuropathies) tend to affect primarily the peripheral nerves, and others affect primarily the CNS (see Table: Disorders That Can Cause CNS Demyelination). The most commonly affected areas in the CNS are the brain, spinal cord, and optic nerves.

Demyelination is often secondary to an infectious, ischemic, metabolic, or hereditary disorder or to a toxin (eg, alcohol, ethambutol). In primary demyelinating disorders, cause is unknown, but an autoimmune mechanism is suspected because the disorder sometimes follows a viral infection or viral vaccination.

Demyelination tends to be segmental or patchy, affecting multiple areas simultaneously or sequentially. Remyelination often occurs, with repair, regeneration, and complete recovery of neural function. However, extensive myelin loss is usually followed by axonal degeneration and often cell body degeneration; both may be irreversible.

Demyelination should be considered in any patient with unexplained neurologic deficits. Primary demyelinating disorders are suggested by the following:

  • Diffuse or multifocal deficits

  • Sudden or subacute onset, particularly in young adults

  • Onset within weeks of an infection or vaccination

  • Deficits that wax and wane

  • Symptoms suggesting a specific demyelinating disorder (eg, unexplained optic neuritis or internuclear ophthalmoplegia suggesting multiple sclerosis)

Specific tests and treatment depend on the specific disorder.

Disorders That Can Cause CNS Demyelination



Hereditary disorders

Phenylketonuria and other aminoacidurias

Krabbe diseaseand other leukodystrophies*

Leber hereditary optic atrophy and related mitochondrial disorders

Hypoxia and ischemia

Carbon monoxide toxicity and other syndromes of delayed hypoxic cerebral demyelination

Progressive subcortical ischemic demyelination

Nutritional deficiencies

Osmotic demyelination syndrome (formerly called central pontine myelinolysis)

Demyelination of the corpus callosum (Marchiafava-Bignami disease)

Direct viral invasion of CNS

Primary demyelinating disorders

Recurrent, progressive disorders (multiple sclerosis and its variants)

Monophasic disorders such as optic neuritis, acute transverse myelitis, acute disseminated encephalomyelitis, and acute hemorrhagic leukoencephalitis



*Some subtypes may also cause peripheral demyelination.

Osmotic demyelination syndrome may also be caused by sodium fluxes.

HTLV-1 = human T-lymphotropic virus 1.

Resources In This Article

Drugs Mentioned In This Article

  • Drug Name
    Select Trade